Oxford Expression Technologies (OET), the award-winning specialist provider of baculovirus-based protein expression solutions, launches a new range of pOET Ligation Independent Cloning (LIC) vectors.
Oxford, UK, July 24, 2012 - Oxford Expression Technologies (OET), the award-winning specialist provider of baculovirus-based protein expression solutions, launches a new range of pOET Ligation Independent Cloning (LIC) vectors. The new LIC vectors facilitate faster and simpler gene transfer into their world renowned flashBAC system for baculovirus protein expression. They are an evolution of the easy to use and highly reliable pOET transfer vectors and provide a host of new advantages over conventional cloning methods.
As the name suggests, ligation independent cloning removes the need to undertake the ligation step in the cloning procedure, this is typically the most troublesome part of any cloning experiment so these new LIC vectors represent obvious benefits to scientists who utilize protein expression techniques.
Passing comment, Richard Broadhead, Sales and Marketing Manager at Oxford Expression Technologies said, “We are pleased to announce the launch of the new pOET ligation independent cloning vectors, they remove a problematic part of the cloning procedure and we are very pleased that we can pass these benefits on to our customers” he continued, “As well as being faster and easier, our latest innovation also allows laboratories to standardize their protocols because there is no need to take into account the length of the insert sequence to be cloned, another benefit conventional cloning methods cannot offer.”
Oxford Expression Technologies invites anyone with an interest in baculovirus protein expression to visit their website - http://oetltd.com/
Oxford Expression Technologies is a biotechnology company specializing in the use of baculovirus vectors, a eukaryotic expression system that can express a large variety of recombinant proteins. Oxford Expression Technologies provides recombinant protein expression products, services and consultancy to many global pharmaceutical companies. The Company’s proprietary flashBAC technology enables large amounts of a given protein to be produced in culture. Its internationally renowned expertise and products enable proteins to be produced faster, more easily and cost-effectively using automated and high-throughput methods compared with other baculovirus expression systems. This contributes to the development of new drugs and research targeted towards understanding how proteins work in health and disease.
The company was founded in 2007 as a result of collaboration between Oxford Brookes University and the Natural Environment Research Council to provide researchers with custom proteins for research purposes.
For Further information or an illustrative image: Media contact - Mathew Taylor, Director, Algorythm Solutions Ltd, mobile: +44 (0)773 403 2112, email: firstname.lastname@example.org, website: www.algorythmsolutions.com